Lionel rostaing

Chairman, Prof

Université Grenoble Alpes

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Lionel Rostaing is the Chairman at Université Grenoble Alpes Grenoble IAE in France. His research areas include the treatment of Hepatitis C virus infections, addressing multidrug-resistant urinary tract infections, and the application of machine learning in predicting outcomes in kidney transplant patients. He has contributed to numerous publications focusing on kidney disease, transplant complications, and the impact of COVID-19 on chronic kidney disease patients.

Articles (22)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (1)

Thomas JOUVE

Professor

Centre Hospitalier Universitaire Vaudois

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Lionel rostaing

Research Interests

Explore related searches

Contact this professor

About

Articles (22)

The Effectiveness of a Sofosbuvir/Daclatasvir Combination in the Treatment of HCV Infection in Patients from Mauritania Undergoing Chronic Hemodialysis

From Pandemic to Resistance: Addressing Multidrug-Resistant Urinary Tract Infections in the Balkans

Urinary Tract Infections Caused by <i>Klebsiella pneumoniae</i> and Prolonged Treatment with Trimethoprim/Sulfamethoxazole

Calcium-Free Dialysate Hemodialysis: A Simplified Approach

Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) for Patients—3-Year Follow-Up of Patients with Chronic Kidney Disease

Is There a Place for Apheresis in the Management of Idiopathic Membranous Nephropathy? A Report of Three Cases and Literature Review

Implementation of Kidney Biopsy in One of the Poorest Countries in the World: Experience from Zinder Hospital (Niger)

Integrating Clinical and Histopathological Data to Predict Delayed Graft Function in Kidney Transplant Recipients Using Machine Learning Techniques

Serum and Urinary Biomarkers in COVID-19 Patients with or without Baseline Chronic Kidney Disease

Tocilizumab Evaluation in HLA-Desensitization before Kidney Transplantation as an Add-On Therapy to Apheresis: The TETRA Study

Adverse Drug Events after Kidney Transplantation

IL-6 and SAA—Strong Predictors for the Outcome in COVID-19 CKD Patients

Idiopathic Nephrotic Syndrome in Children in Chad: Epidemiology and Clinical Outcomes

Early Exposure of Kidney Transplant Recipients with Chronic Antibody-Mediated Rejection to Tocilizumab—A Preliminary Study

COVID-19 Infection in Chronic Kidney Disease Patients in Bulgaria: Risk Factors for Death and Acute Kidney Injury

Genomic Mutations of BK Polyomavirus in Patients after Kidney Transplantation: A Cross-Sectional Study in Vietnam

Kidney Transplantation for Focal Segmental Glomerulosclerosis: Can We Prevent Its Recurrence? Personal Experience and Literature Review

Tocilizumab Trough Levels Variability in Kidney-Transplant Candidates Undergoing Desensitization

Belatacept Use after Kidney Transplantation and Its Effects on Risk of Infection and COVID-19 Vaccine Response

Tocilizumab and Desensitization in Kidney Transplant Candidates: Personal Experience and Literature Review

Protocol Biopsies on de novo Renal-Transplants at 3 Months after Surgery: Impact on 5-Year Transplant Survival

Apheresis Efficacy and Tolerance in the Setting of HLA-Incompatible Kidney Transplantation

Collaborators (1)

Thomas JOUVE

Make your next move.